Evonik
Paul Nichols is a highly experienced professional in the field of process research, development, and innovation, currently serving as the Director of Process Research, Development and Innovation at Evonik Operations GmbH since June 2017. Nichols oversees process development and research at production sites in Germany, offering specialized technology platforms for internal and customer projects, including chemo and bio-catalysis and flow chemistry. Prior to this role, Nichols held significant positions at Tippecanoe Laboratories, Noramco, Inc., PCI Synthesis, Array BioPharma, and Abbott, demonstrating expertise in project management, large molecule fermentation, and small molecule clinical candidate development. Nichols holds a Ph.D. in Organic Chemistry from the University of Colorado Boulder, an MS in Organic Chemistry from San Diego State University, and dual BA degrees in Chemistry and Psychology from UC San Diego.
This person is not in any teams
This person is not in any offices
Evonik
12 followers
Evonik is a Germany-based specialty chemicals company that operates in four segments: The Nutrition and Care segment produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as nutrition for animal food and healthcare products; the Resource Efficiency segment offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; the Performance Materials segment produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and the Services segment comprises site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at the Company's sites. Its majority shareholder is RAG Stiftung.